Company / Current Assets
OCULAR THERAPEUTIX, INC Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$782.1M
FY2025
5-year range
$129.6M / $782.1M
FY2021-FY2025
Trend
+77.4%
vs FY2024
Sector context
#72 of 213
Health Care
What the data says
At $782M, OCULAR THERAPEUTIX, INC's current assets ranks #72 of 213 in the Health Care sector. Current Assets has increased for 3 consecutive years, from $130M in FY2022 to $782M in FY2025.
Based on SEC 10-K filings.
$782M in FY2025 with a 5-year CAGR of +26.0%.
Improved from $232M to $782M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +82.1%
- 5-Year CAGR
- +26.0%
- 10-Year CAGR
- -
Sector benchmark
#72 of 213 in Health CareTop 34% of 213This company $782.1M Sector average $2.5B
▼
-69.0% below sector average
Key checks
Key Insights
- OCULAR THERAPEUTIX, INC's current assets has grown for 3 consecutive years.
- 5-year CAGR of +26.0%, indicating consistent growth.
- In FY2025, current assets increased 77.4% year-over-year.
- Ranks #72 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $782.1M | +77.4% |
| FY2024 | $441.0M | +89.9% |
| FY2023 | $232.2M | +79.2% |
| FY2022 | $129.6M | -32.2% |
| FY2021 | $191.3M | -22.3% |
| FY2020 | $246.2M | +309.1% |
| FY2019 | $60.2M | +7.1% |
| FY2018 | $56.2M | +29.7% |
| FY2017 | $43.3M | -38.0% |
| FY2016 | $69.9M | -34.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026